Genic Co. Ltd (123330) — Cash Flow-to-Debt Ratio
Genic Co. Ltd (123330) has a Cash Flow-to-Debt Ratio of -0.25x as of March 2026, meaning its operating cash flow of ₩-5.54 Billion could theoretically repay 0% of its total liabilities (₩22.34 Billion) in one year. Explore Genic Co. Ltd (123330) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genic Co. Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Genic Co. Ltd across 14 annual periods. Also explore Genic Co. Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Genic Co. Ltd (2012–2025)
Year-by-year debt coverage analysis for Genic Co. Ltd. For market capitalisation and broader financial context, see 123330 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | ₩20.65 Billion | ₩15.49 Billion | ▲ +7732.4% |
| 2024 | 0.02x | ₩272.46 Million | ₩16.00 Billion | ▲ +175.3% |
| 2023 | -0.02x | ₩-268.31 Million | ₩11.87 Billion | ▼ -283.1% |
| 2022 | 0.01x | ₩177.94 Million | ₩14.41 Billion | ▼ -90.3% |
| 2021 | 0.13x | ₩3.32 Billion | ₩26.11 Billion | ▲ +1561.8% |
| 2020 | 0.01x | ₩212.66 Million | ₩27.77 Billion | ▼ -82.8% |
| 2019 | 0.04x | ₩1.38 Billion | ₩31.01 Billion | ▲ +117.1% |
| 2018 | -0.26x | ₩-8.90 Billion | ₩34.37 Billion | ▼ -147.9% |
| 2017 | -0.10x | ₩-4.09 Billion | ₩39.11 Billion | ▼ -315.1% |
| 2016 | 0.05x | ₩1.93 Billion | ₩39.63 Billion | ▼ -61.2% |
| 2015 | 0.13x | ₩3.63 Billion | ₩28.97 Billion | ▼ -56.1% |
| 2014 | 0.29x | ₩5.80 Billion | ₩20.34 Billion | ▼ -9.2% |
| 2013 | 0.31x | ₩3.68 Billion | ₩11.70 Billion | ▼ -47.5% |
| 2012 | 0.60x | ₩4.31 Billion | ₩7.20 Billion | — |